COVID cases surge in China following relaxed restrictions
Hospitals in China have been struggling to contain a rising COVID-19 outbreak as authorities scale back on over two years of strict COVID policies, The Washington Post reports.
Last week following widespread protests against the government's strict zero COVID policies, authorities decided to loosen some of the severe restrictions under the policy after two years. Beijing declared that people who tested positive for the virus could quarantine at home instead of being forced into government facilities if they are asymptomatic or have mild symptoms. Requirements for testing, digital health passes, and tracking also loosened dramatically.
Since that announcement, hospitals have reported a surge in COVID patients, while hundreds of staff members have become infected with the virus. At a briefing, Beijing municipal officials said 22,000 patients visited fever clinics on Sunday, which is 16 times the daily average of the prior week, per the Post. Long lines have been forming outside of hospitals as medical professionals struggle to keep up with the demand for care. Some facilities are struggling to find enough staff, leading some centers to suspend non-COVID treatments, Bloomberg reports.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Officials are urging people not to use the capital's emergency medical hotline unless they have severe symptoms, warning that a spike in requests for help could prevent those who are critically ill from getting through, per Bloomberg. The capital has erected triple the number of fever clinics and pledged to open more. Instead, authorities suggested residents seek assistance from community clinics instead of going to the hospital.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Ultimate pasta alla NormaThe Week Recommends White miso and eggplant enrich the flavour of this classic pasta dish
-
Death in Minneapolis: a shooting dividing the USIn the Spotlight Federal response to Renee Good’s shooting suggest priority is ‘vilifying Trump’s perceived enemies rather than informing the public’
-
5 hilariously chilling cartoons about Trump’s plan to invade GreenlandCartoons Artists take on misdirection, the need for Greenland, and more
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
How China is battling the chikungunya virusUnder The Radar Thousands of cases of the debilitating disease have been found in the country
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
